A detailed history of Persium Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Persium Advisors, LLC holds 30,066 shares of PFE stock, worth $742,329. This represents 0.57% of its overall portfolio holdings.

Number of Shares
30,066
Previous 27,123 10.85%
Holding current value
$742,329
Previous $657 Million 16.52%
% of portfolio
0.57%
Previous 0.54%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

BUY
$23.29 - $25.88 $68,542 - $76,164
2,943 Added 10.85%
30,066 $766 Million
Q2 2025

Jul 08, 2025

BUY
$21.59 - $24.84 $163,846 - $188,510
7,589 Added 38.85%
27,123 $657 Million
Q1 2025

Apr 11, 2025

BUY
$25.01 - $27.13 $488,545 - $529,957
19,534 New
19,534 $495 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Persium Advisors, LLC Portfolio

Follow Persium Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Persium Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Persium Advisors, LLC with notifications on news.